We assisted Quality by Design (QbD Group), a leading provider of life science services, in its acquisition of regulatory affairs and pharmacovigilance specialist EUDRAC as lead corporate finance advisor.
Services
- Identify and evaluate potential targets that align with QbD's strategic objectives
- Initiate discussions, develop assessments, and submit letters of intent with identified target companies
- Coordinate and execute due diligence and final purchase agreement negotiations